Puma Biotechnology (PBYI) Non-cash Items (2012 - 2026)
Puma Biotechnology (PBYI) reported Non-cash Items of $4.2 million for Q1 2026, up 1081.13% on a YoY basis from $355000.0 in Q1 2025, and up 16.18% quarter-over-quarter from $3.6 million in Q4 2025.
Puma Biotechnology (PBYI) Non-cash Items (2012 - 2026) Analysis & Trends
Puma Biotechnology has reported Non-cash Items for 15 years, with the latest figure at $4.2 million in Q1 2026.
- For the quarter ending Q1 2026, Non-cash Items rose 1081.13% year-over-year to $4.2 million; the trailing twelve-month figure through Mar 2026 stood at $4.2 million (up 1081.13% YoY), and the FY2025 full-year result was $3.6 million, changed 0.34% from the prior year.
- Non-cash Items for Q1 2026 stood at $4.2 million, up from $3.6 million in the prior quarter.
- The five-year high for Non-cash Items was $4.2 million in Q1 2026, with the low at $19000.0 in Q3 2022.
- Historically, Non-cash Items has averaged $2.1 million across 5 years, with a median of $2.2 million in 2024.
- Annual changes were most pronounced in 2022 — Non-cash Items tumbled 98.24% — and 2025, when it surged 3321.42%.
- Puma Biotechnology's Non-cash Items stood at $1.0 million in 2022, then gained by 5.64% to $1.1 million in 2023, then jumped by 227.72% to $3.6 million in 2024, then fell by 0.34% to $3.6 million in 2025, then grew by 16.18% to $4.2 million in 2026.
- The last three Non-cash Items figures came in at $4.2 million (Q1 2026), $3.6 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Puma Biotechnology | 384.39 Mn | 282.84 Mn | 34.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.19 Mn |
| Mar 31, 2026 | 4.19 Mn |
| Dec 31, 2025 | 3.61 Mn |
| Dec 31, 2025 | 3.61 Mn |
| Sep 30, 2025 | 3.15 Mn |
| Sep 30, 2025 | 3.15 Mn |
| Jun 30, 2025 | 726,000.00 |
| Jun 30, 2025 | 726,000.00 |
| Mar 31, 2025 | 355,000.00 |
| Mar 31, 2025 | 355,000.00 |
| Dec 31, 2024 | 3.62 Mn |
| Dec 31, 2024 | 3.62 Mn |
| Sep 30, 2024 | 92,000.00 |
| Sep 30, 2024 | 92,000.00 |
| Jun 30, 2024 | 3.97 Mn |
| Jun 30, 2024 | 3.97 Mn |
| Mar 31, 2024 | 2.20 Mn |
| Mar 31, 2024 | 2.20 Mn |
| Dec 31, 2023 | 1.11 Mn |
| Dec 31, 2023 | 1.11 Mn |